$CORT

Corcept Therapeutics Inc

  • NASDAQ
  • Health Technology
  • Pharmaceuticals: Other
  • Manufacturing
  • Pharmaceutical Preparation Manufacturing

PRICE

$25.73 โ–ฒ1.14%

Last Close

VOLUME

894,269

DAY RANGE

24.99 - 25.99

52 WEEK

15.83 - 25.99

Join Discuss about CORT with like-minded investors

profile
@dros #droscrew
recently

+Initiations 6/27: $ACM $AXTI $BLBX $CORT $DRI $ENOV $GROV $IFF $LQDT $ML $RPM $SIGI $TXRH . -Initiations 6/27: $ALB $BPMC $CE $EAT $LYB $ORCL

110 Replies 6 ๐Ÿ‘ 11 ๐Ÿ”ฅ

profile
@dros #droscrew
recently

Unusually active option classes on open December 16th $BEKE $CORT $KGC $VRM $UPS $T $NVAX $SHOP $BKKT $NVDA

77 Replies 7 ๐Ÿ‘ 11 ๐Ÿ”ฅ

profile
@maletone #StockTraders.NET
recently

$CORT green

96 Replies 8 ๐Ÿ‘ 7 ๐Ÿ”ฅ

profile
@TraderXx #StockTraders.NET
recently

stabbed some ss on $CORT here

117 Replies 7 ๐Ÿ‘ 11 ๐Ÿ”ฅ

profile
@maletone #StockTraders.NET
recently

wow $CORT picking up steam

131 Replies 7 ๐Ÿ‘ 10 ๐Ÿ”ฅ

profile
@TraderXx #StockTraders.NET
recently

$CORT 20.50's will be interesting

120 Replies 11 ๐Ÿ‘ 14 ๐Ÿ”ฅ

SO
@soheil.n #StockTraders.NET
recently

Possible first red days: $GOGO, $SHLL, $CORT, $FEAC, $FMCI

70 Replies 12 ๐Ÿ‘ 11 ๐Ÿ”ฅ

profile
@Neptune5045 #StockTraders.NET
recently

congrats to $CORT ss

147 Replies 11 ๐Ÿ‘ 12 ๐Ÿ”ฅ

profile
@FillTheGapToZero #StockTraders.NET
recently

taking $CORT long here 19.70

133 Replies 12 ๐Ÿ‘ 6 ๐Ÿ”ฅ

profile
@CarlosH-carvan #ivtrades
recently

wow $CORT today

62 Replies 10 ๐Ÿ‘ 15 ๐Ÿ”ฅ

profile
@TraderXx #StockTraders.NET
recently

$CORT 88M Float!? hmmm

140 Replies 13 ๐Ÿ‘ 9 ๐Ÿ”ฅ

profile
@TraderXx #StockTraders.NET
recently

whats up with $CORT ? not seeing anything on it

129 Replies 8 ๐Ÿ‘ 8 ๐Ÿ”ฅ

SJ
@sj2343 #StockTraders.NET
recently

long CORT for rip into close

45 Replies 13 ๐Ÿ‘ 11 ๐Ÿ”ฅ

profile
@FillTheGapToZero #StockTraders.NET
recently

I wouldnโ€™t even short CORT here

97 Replies 11 ๐Ÿ‘ 14 ๐Ÿ”ฅ

profile
@maletone #StockTraders.NET
recently

shorting weakness on CORT is how it traps shorts

119 Replies 11 ๐Ÿ‘ 15 ๐Ÿ”ฅ

profile
@DHouse #StockTraders.NET
recently

CORT had big calls coming in at 19, 20 level, majority institutionally owned, very high float yet up 100%... so that was my confirmation not to enter , or if i did, be supremely nimble

93 Replies 9 ๐Ÿ‘ 11 ๐Ÿ”ฅ

profile
@FillTheGapToZero #StockTraders.NET
recently

anyone see $CORT

122 Replies 9 ๐Ÿ‘ 9 ๐Ÿ”ฅ

profile
@viking #StockTraders.NET
recently

whats the news on $CORT anyway

130 Replies 15 ๐Ÿ‘ 8 ๐Ÿ”ฅ

profile
@maletone #StockTraders.NET
recently

glad I covered most on $CORT

148 Replies 9 ๐Ÿ‘ 14 ๐Ÿ”ฅ

WI
@WINTERTRADE #StockTraders.NET
recently

there goes CORT

125 Replies 7 ๐Ÿ‘ 7 ๐Ÿ”ฅ

profile
@Math #StockTraders.NET
recently

covered 1/2 CORT low 18s

136 Replies 12 ๐Ÿ‘ 9 ๐Ÿ”ฅ

AN
@andres168 #StockTraders.NET
recently

Cov some $cort

131 Replies 8 ๐Ÿ‘ 6 ๐Ÿ”ฅ

profile
@DHouse #StockTraders.NET
recently

92 Replies 7 ๐Ÿ‘ 8 ๐Ÿ”ฅ

profile
@maletone #StockTraders.NET
recently

only got 500 shares left in $CORT

89 Replies 7 ๐Ÿ‘ 9 ๐Ÿ”ฅ

profile
@DHouse #StockTraders.NET
recently

dont understand CORT at all

70 Replies 9 ๐Ÿ‘ 14 ๐Ÿ”ฅ

profile
@dros #droscrew
recently

Largest Call/Put Ratio: $CORT

114 Replies 11 ๐Ÿ‘ 13 ๐Ÿ”ฅ

profile
@CarlosH-carvan #ivtrades
recently

uoa $CORT 18C Sept

55 Replies 14 ๐Ÿ‘ 11 ๐Ÿ”ฅ

profile
@Benlax #droscrew
recently

$ASND At $5.5B EV ( $1B in cash) this is compelling risk / reward with big upside from these levels imo. Had to free some cash. Sold out $CORT due to not as high conviction (Teva lawsuit bothers me lol) plus profit is profit. Summary: -Derisked gHD (growth hormone deficiency) best in class ONCE-WEEKLY therapy. Standard of care currenttly are daily injections of hGH. - Based on P2 data de-risked to great extent HP (hypoparathyroidism) PTH compound. Potentially superior over Natpara that's currently recalled by FDA. Patients desperately need new therapies here. > $1B on peak rev potential. raps.org/news-and-articles/... - Transcon CNP in P2 trial for Achondroplasia. Currently there are NO any FDA-approved treatments to address this most common type of dwarfism. - Move into Oncology therapeutic area based on Vision 3x3 strategic roadmap. 3rd therapeutic area for TransCon TBD

45 Replies 10 ๐Ÿ‘ 8 ๐Ÿ”ฅ

Key Metrics

Market Cap

2.73 B

Beta

0.79

Avg. Volume

735.64 K

Shares Outstanding

106.25 M

Yield

0%

Public Float

0

Next Earnings Date

2022-07-28

Next Dividend Date

Company Information

Corcept is a commercial-stage company engaged in the discovery and development of drugs to treat severe metabolic, oncologic and psychiatric disorders by modulating the effects of the hormone cortisol. Korlymยฎ was the first drug approved by the U.S. Food and Drug Administration for patients with Cushing's syndrome. Corcept has discovered a large portfolio of proprietary compounds that selectively modulate the effects of cortisol. The company owns extensive United States and foreign intellectual property covering the composition of its selective cortisol modulators and the use of cortisol modulators to treat a variety of serious disorders.

CEO: Joseph Belanoff

Website:

HQ: 149 Commonwealth Dr Menlo Park, 94025-1133 California

Related News